0000001800 true On May 2, 2023, Abbott filed a Current Report on Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2023 (the "Original Report"). This amendment corrects the number of shares cast against Michael F. Roman, which was reported incorrectly in the Original Report due to a typographical error. Common Shares, Without Par Value ABT 0000001800 2023-04-28 2023-04-28 0000001800 us-gaap:CommonStockMember exch:XCHI 2023-04-28 2023-04-28 0000001800 us-gaap:CommonStockMember exch:XNYS 2023-04-28 2023-04-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
   

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

 

 

FORM 8-K/A

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

April 28, 2023

Date of Report (Date of earliest event reported)

  

ABBOTT LABORATORIES

(Exact name of registrant as specified in charter)

 

 

 

Illinois   1-2189   36-0698440
(State or other Jurisdiction   (Commission File Number)   (IRS Employer
of Incorporation)       Identification No.)

 

 

 

100 Abbott Park Road

Abbott Park, Illinois 60064-6400

(Address of principal executive offices)(Zip Code)

 

Registrant’s telephone number, including area code:  (224) 667-6100

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities Registered Pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading
Symbol(s)

Name of Each Exchange on Which
Registered

Common Shares, Without Par Value ABT New York Stock Exchange
 Chicago Stock Exchange, Inc.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

Item 5.07 — Submission of Matters to a Vote of Security Holders.

 

On May 2, 2023, Abbott filed a Current Report on Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2023 (the “Original Report”). This amendment corrects the number of shares cast against Michael F. Roman, which was reported incorrectly in the Original Report due to a typographical error.

 

The number of shares cast for, the number against, the number abstaining, and the number of broker non-votes, with respect to Mr. Roman, were as follows:

 

Name  Votes For  Votes Against  Abstain  Broker Non-Votes
Michael F. Roman  1,315,610,421  25,575,883  2,597,363  179,678,846

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ABBOTT LABORATORIES
   
   
Date: September 1, 2023 By: /s/ Hubert L. Allen
    Hubert L. Allen.
    Executive Vice President, General Counsel and Secretary